Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic NSCLC
Clinical trial NCT03527108 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03527108
- Sponsor
- Fox Chase Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-08
- Primary completion
- 2026-12-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.